Literature DB >> 19930906

Role of cholinergic anti-inflammatory pathway in regulating host response and its interventional strategy for inflammatory diseases.

Da-wei Wang1, Rong-bin Zhou, Yong-ming Yao.   

Abstract

The cholinergic anti-inflammatory pathway (CAP) is a neurophysiological mechanism that regulates the immune system. The CAP inhibits inflammation by suppressing cytokine synthesis via release of acetylcholine in organs of the reticuloendothelial system, including the lungs, spleen, liver, kidneys and gastrointestinal tract. Acetylcholine can interact with alpha7 nicotinic acetylcholine receptors (alpha7 nAchR) expressed by macrophages and other cytokine producing cells, down-regulate pro-inflammatory cytokine synthesis and prevent tissue damage. Herein is a review of the neurophysiological mechanism in which the CAP regulates inflammatory response, as well as its potential interventional strategy for inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19930906

Source DB:  PubMed          Journal:  Chin J Traumatol        ISSN: 1008-1275


  14 in total

1.  Changes of neuronal acetylcholine receptor alpha 7 of peritoneal macrophage in experimental acute pancreatitis treated by Chaiqin Chengqi Decoction ().

Authors:  Ping Xue; Jia Guo; Xiao-nan Yang; Wei Huang; Qing Xia
Journal:  Chin J Integr Med       Date:  2014-01-23       Impact factor: 1.978

2.  Galantamine effect on tularemia pathogenesis in a BALB/c mouse model.

Authors:  Miroslav Pohanka; Oto Pavlis; Jiri Pikula
Journal:  Iran Biomed J       Date:  2012

3.  Nicotinic receptor subunit alpha5 modifies assembly, up-regulation, and response to pro-inflammatory cytokines.

Authors:  Lorise C Gahring; Scott W Rogers
Journal:  J Biol Chem       Date:  2010-06-21       Impact factor: 5.157

4.  Gastrointestinal neuroimmune disruption in a mouse model of Gulf War illness.

Authors:  Siomara Hernandez; David E Fried; Vladimir Grubišić; Jonathon L McClain; Brian D Gulbransen
Journal:  FASEB J       Date:  2019-02-21       Impact factor: 5.191

Review 5.  Alpha7 nicotinic receptors as novel therapeutic targets for inflammation-based diseases.

Authors:  Merouane Bencherif; Patrick M Lippiello; Rudolf Lucas; Mario B Marrero
Journal:  Cell Mol Life Sci       Date:  2010-10-15       Impact factor: 9.261

6.  Effects of α7 positive allosteric modulators in murine inflammatory and chronic neuropathic pain models.

Authors:  Kelen Freitas; Sudeshna Ghosh; F Ivy Carroll; Aron H Lichtman; M Imad Damaj
Journal:  Neuropharmacology       Date:  2012-10-16       Impact factor: 5.250

Review 7.  Antidepressant effects of the muscarinic cholinergic receptor antagonist scopolamine: a review.

Authors:  Wayne C Drevets; Carlos A Zarate; Maura L Furey
Journal:  Biol Psychiatry       Date:  2012-11-28       Impact factor: 13.382

8.  Berberine relieves insulin resistance via the cholinergic anti-inflammatory pathway in HepG2 cells.

Authors:  Fen Li; Yun-Bin Zhao; Ding-Kun Wang; Xin Zou; Ke Fang; Kai-Fu Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-02-03

9.  Dysregulated Homeostasis of Acetylcholine Levels in Immune Cells of RR-Multiple Sclerosis Patients.

Authors:  Maria Di Bari; Marcella Reale; Marta Di Nicola; Viviana Orlando; Sabrina Galizia; Italo Porfilio; Erica Costantini; Chiara D'Angelo; Serena Ruggieri; Stefano Biagioni; Claudio Gasperini; Ada Maria Tata
Journal:  Int J Mol Sci       Date:  2016-11-30       Impact factor: 5.923

10.  An experimental study on (131)I-CHIBA-1001: a radioligand for α7 nicotinic acetylcholine receptors.

Authors:  Lei Yin; Qian Zhao; Ling Li; Su Lei Zhang; Xue Qi Chen; Chao Ma; Lei Kang; Meng Liu; Chun Li Zhang; Ping Yan; Rong Fu Wang
Journal:  PLoS One       Date:  2013-07-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.